Sulfonmethane: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{Short description|A sedative and hypnotic drug}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| IUPAC_name = 2,2-bis(ethylsulfonyl)propane | |||
| image = Sulfonmethane.svg | |||
| image2 = Sulfonmethane-3D-balls.png | |||
| image2_caption = Ball-and-stick model of sulfonmethane | |||
| tradename = Sulfonal | |||
| CAS_number = 115-24-2 | |||
| ATC_prefix = N05 | |||
| ATC_suffix = CM10 | |||
| PubChem = 6851 | |||
| ChemSpiderID = 6591 | |||
| UNII = 0K8C52507Q | |||
| KEGG = D07268 | |||
| ChEBI = 32182 | |||
| ChEMBL = 1201290 | |||
| C=5 | |||
| H=12 | |||
| O=4 | |||
| S=2 | |||
| SMILES = CC(S(=O)(=O)C(C)(C)S(=O)(=O)CC)CC | |||
| StdInChI = 1S/C7H16O4S2/c1-5-12(8,9)7(3,4)13(10,11)6-2/h5-6H2,1-4H3 | |||
| StdInChIKey = ZJQHPWUVQPJDKF-UHFFFAOYSA-N | |||
}} | |||
'''Sulfonmethane''', also known as '''sulfonal''', is a [[sedative]] and [[hypnotic]] drug that was historically used to treat [[insomnia]] and other sleep disorders. It belongs to the class of [[organosulfur compounds]] and is chemically classified as a [[sulfone]]. | |||
Sulfonmethane is a | |||
== | ==History== | ||
Sulfonmethane | Sulfonmethane was first synthesized in the late 19th century by the German chemist [[Eugen Baumann]]. It was introduced into medical practice in the 1880s as a sedative and hypnotic agent. During this period, it was commonly used to induce sleep in patients suffering from insomnia and other sleep-related disorders. | ||
==Chemical Structure and Properties== | |||
Sulfonmethane is a symmetrical molecule with the chemical formula C<sub>7</sub>H<sub>16</sub>O<sub>4</sub>S<sub>2</sub>. It consists of a central propane backbone with two ethylsulfonyl groups attached to the second carbon atom. The presence of these sulfonyl groups is responsible for its sedative properties. | |||
[[File:Sulfonmethane-3D-balls.png|thumb|left|Ball-and-stick model of sulfonmethane]] | |||
Sulfonmethane | |||
== | ==Pharmacology== | ||
Sulfonmethane acts as a central nervous system [[depressant]]. It enhances the activity of the inhibitory neurotransmitter [[gamma-aminobutyric acid]] (GABA) in the brain, leading to sedative and hypnotic effects. This mechanism of action is similar to that of other [[barbiturates]], although sulfonmethane is chemically distinct from them. | |||
== | ==Medical Use== | ||
Historically, sulfonmethane was used to treat insomnia and other sleep disorders. It was administered orally in the form of tablets or powders. However, due to the development of safer and more effective sedative-hypnotic drugs, such as [[benzodiazepines]], the use of sulfonmethane has declined significantly. | |||
==Side Effects== | |||
The use of sulfonmethane can lead to several side effects, including [[drowsiness]], [[dizziness]], and [[headache]]. In some cases, it may cause [[gastrointestinal disturbances]] such as [[nausea]] and [[vomiting]]. Prolonged use can lead to [[tolerance]] and [[dependence]], similar to other sedative-hypnotic drugs. | |||
==Current Status== | |||
Today, sulfonmethane is rarely used in clinical practice due to the availability of newer and safer alternatives. It is primarily of historical interest and is studied for its role in the development of sedative-hypnotic pharmacology. | |||
==Related pages== | |||
* [[Sedative]] | |||
* [[Hypnotic]] | |||
* [[Insomnia]] | |||
* [[Barbiturate]] | |||
* [[Benzodiazepine]] | |||
[[Category:Sedatives]] | |||
[[Category:Hypnotics]] | |||
[[Category:Organosulfur compounds]] | [[Category:Organosulfur compounds]] | ||
[[Category: | [[Category:History of medicine]] | ||
Revision as of 17:42, 18 February 2025
A sedative and hypnotic drug
| Sulfonmethane | |
|---|---|
| File:Sulfonmethane.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 115-24-2 |
| PubChem | 6851 |
| DrugBank | |
| ChemSpider | 6591 |
| KEGG | D07268 |
Sulfonmethane, also known as sulfonal, is a sedative and hypnotic drug that was historically used to treat insomnia and other sleep disorders. It belongs to the class of organosulfur compounds and is chemically classified as a sulfone.
History
Sulfonmethane was first synthesized in the late 19th century by the German chemist Eugen Baumann. It was introduced into medical practice in the 1880s as a sedative and hypnotic agent. During this period, it was commonly used to induce sleep in patients suffering from insomnia and other sleep-related disorders.
Chemical Structure and Properties
Sulfonmethane is a symmetrical molecule with the chemical formula C7H16O4S2. It consists of a central propane backbone with two ethylsulfonyl groups attached to the second carbon atom. The presence of these sulfonyl groups is responsible for its sedative properties.
Pharmacology
Sulfonmethane acts as a central nervous system depressant. It enhances the activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to sedative and hypnotic effects. This mechanism of action is similar to that of other barbiturates, although sulfonmethane is chemically distinct from them.
Medical Use
Historically, sulfonmethane was used to treat insomnia and other sleep disorders. It was administered orally in the form of tablets or powders. However, due to the development of safer and more effective sedative-hypnotic drugs, such as benzodiazepines, the use of sulfonmethane has declined significantly.
Side Effects
The use of sulfonmethane can lead to several side effects, including drowsiness, dizziness, and headache. In some cases, it may cause gastrointestinal disturbances such as nausea and vomiting. Prolonged use can lead to tolerance and dependence, similar to other sedative-hypnotic drugs.
Current Status
Today, sulfonmethane is rarely used in clinical practice due to the availability of newer and safer alternatives. It is primarily of historical interest and is studied for its role in the development of sedative-hypnotic pharmacology.